A 25-year-old woman with a history of childhood asthma presents with daytime wheeze and cough three times per week and nighttime symptoms once weekly. She uses her salbutamol inhaler two to three times weekly. Spirometry shows FEV1 85 percent predicted with reversible obstruction. According to Canadian asthma guidelines, what is the most appropriate next step in pharmacologic management?